Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Gina Jamal, MD

Articles by Gina Jamal, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
February 3rd 2025

Trending on Psychiatric Times

Comparison of Atypical Antipsychotics as Adjunctive Treatments for Major Depressive Disorder

Improving but Not Feeling It: Anticipatory Anhedonia and Cognition

ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function

Evidence-Based Ethical Principles for Long-Acting Injectable Antipsychotic Use

What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?